Crewe Advisors’s Bio-Techne TECH Stock Holding History

Crewe Advisors’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-44	Closed	-$3K	–	1259
2022 Q3	$3K	Hold	44	–	–	﹤0.01%	992
2022 Q2	$4K	Buy	+44	New	+$4.12K	﹤0.01%	843

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Crewe Advisors's TECH Position: Q4 2022 in Review

Crewe Advisors sold out of Bio-Techne (TECH) in Q4 2022, closing a stake of 44 shares — an estimated $3K sold.

Crewe Advisors first reported a position in TECH in Q2 2022 and held it in 2 quarters. The position peaked at $4K in Q2 2022. 545 funds tracked by Wall St. Rank hold TECH as of Q4 2022.

Crewe Advisors reported no remaining Bio-Techne position as of Q4 2022 after selling out during the quarter.
Crewe Advisors sold 44 Bio-Techne shares in Q4 2022, an estimated $3K.
Crewe Advisors first reported a position in Bio-Techne in Q2 2022 and held it in 2 quarters.
Crewe Advisors's Bio-Techne position peaked at $4K in Q2 2022.
545 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2022.

Based on Crewe Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.